Nancy A. Rodriguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nancy A. Rodriguez has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Donna J. Miracle
Rush University Medical Center
1 shared publicationJ M Zeller
Rush University College of Nursing, Rush University Medical Center, Chicago, IL, USA
1 shared publicationM W Groer
University of South Florida College of Nursing, Tampa, FL, USA
1 shared publicationP P Meier
Rush University College of Nursing, Rush University Medical Center, Chicago, IL, USA
1 shared publicationPaula P. Meier
Rush University Medical Center
1 shared publication
Latest Publications
- Open Access
- 4 September 2008
- Published by Springer Nature in Journal of Perinatology
- Vol. 29 (1) , 1-7
Oropharyngeal administration of colostrum to extremely low birth weight infants: theoretical perspectives
Studies in adults have shown that the oropharyngeal route can be used to effectively and safely administer interferon-α, an immune cell-derived cytokine, to patients who are unable to tolerate its parenteral administration. The mechanism for this appears to be the stimulatory effects of the cytokine, on the oropharyngeal-associated lymphoid tissue system. Own mother's colostrum (OMC) is rich in cytokines and other immune agents that provide bacteriostatic, bacteriocidal, antiviral, anti-inflammatory and immunomodulatory protection against infection. OMC may be especially protective for the extremely low birth weight (ELBW) infant in the first days of life; however clinical instability typically precludes enteral feedings during this period. Oropharyngeal administration is a potential alternative method of providing OMC. Oropharyngeal administration of OMC may have immunomodulatory effects on the recipient infant, and would be especially beneficial to the ELBW infant who would otherwise remain nil per os during the first days of life.
- 4 September 2008
- Published by Springer Nature in Journal of Perinatology
- Vol. 29 (1) , 1-7
Open AccessOropharyngeal administration of colostrum to extremely low birth weight infants: theoretical perspectives
Studies in adults have shown that the oropharyngeal route can be used to effectively and safely administer interferon-α, an immune cell-derived cytokine, to patients who are unable to tolerate its parenteral administration. The mechanism for this appears to be the stimulatory effects of the cytokine, on the oropharyngeal-associated lymphoid tissue system. Own mother's colostrum (OMC) is rich in cytokines and other immune agents that provide bacteriostatic, bacteriocidal, antiviral, anti-inflammatory and immunomodulatory protection against infection. OMC may be especially protective for the extremely low birth weight (ELBW) infant in the first days of life; however clinical instability typically precludes enteral feedings during this period. Oropharyngeal administration is a potential alternative method of providing OMC. Oropharyngeal administration of OMC may have immunomodulatory effects on the recipient infant, and would be especially beneficial to the ELBW infant who would otherwise remain nil per os during the first days of life.
- 1 January 2005
- Published by Elsevier in Journal of Obstetric, Gynecologic, & Neonatal Nursing
- Vol. 34 (1) , 109-119
Sharing the Science on Human Milk Feedings With Mothers of Very-Low-Birth-Weight Infants
- 1 January 2005
- Published by Elsevier in Journal of Obstetric, Gynecologic, & Neonatal Nursing
- Vol. 34 (1) , 109-119
Sharing the Science on Human Milk Feedings With Mothers of Very-Low-Birth-Weight Infants